Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-06-01

Clinical Trial Update: 24-Hour NAVA Ventilation in Acute Respiratory Failure [NA]

View source ↗

Summary

The study evaluating 24-hour Neurally Adjusted Ventilation (NAVA) in acute respiratory failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Unity Health Toronto | Conditions: Respiration, Artificial, Respiratory Insufficiency | NA | Status: COMPLETED